P3 Health Partners (PIII) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 Annual Meeting, with nominees Amir Bacchus, M.D., Mark Thierer, and Lawrence B. Leisure recommended for election.
Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory approval of executive compensation for named executive officers.
Approval of the issuance of up to 3,341,130 shares of Class A common stock upon exercise of outstanding warrants held by VBC Growth SPV 5, LLC, in accordance with Nasdaq Listing Rule 5635(d).
Consideration of any other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all director nominees for election to serve until 2029, ensuring continuity in governance.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.
Latest events from P3 Health Partners
- Shareholders will vote on director elections, auditor ratification, executive pay, and warrant share issuance.PIII
Proxy filing30 Apr 2026 - Board recommends approval of all proposals, including director elections and share issuance.PIII
Proxy filing20 Apr 2026 - Value-based care model targets $1.7B revenue and positive EBITDA in 2026, led by seasoned executives.PIII
Investor presentation30 Mar 2026 - 2026 outlook projects a $170M EBITDA improvement and 29,000 new Medicare Advantage members.PIII
Q4 202526 Mar 2026 - Operational focus and technology upgrades target margin growth and cash flow positivity by 2025.PIII
17th Annual LD Micro Main Event Conference13 Feb 2026 - Q2 revenue up 15% to $379M, but profitability declined and liquidity risks remain.PIII
Q2 20242 Feb 2026 - Membership and revenue surge, tech innovation, and efficiency drive future growth.PIII
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Tech-enabled value-based care and disciplined growth drive profitability and expansion.PIII
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Revenue up 26% year-over-year, but net loss widened and liquidity risks persist.PIII
Q3 202414 Jan 2026